¡°	carbidopa levodopa combination	9.888703583700895
	HPC polymer	9.2204413316364
	HPC HPMC polymer vehicle	8.478683806449556
	Markush form	6.55043370431234
	PVACA copolymer	5.97619950828803
	Sheth formulation	5.325911340859839
	hydroxypropyl cellulose	3.64584215035071
	Schor	3.4989553307999923
	water soluble hpc polymer	2.2937491953551508
	schor	1.9757988528582673
	acronym	1.5889409421284721
	mg	1.3959593096253258
	less water soluble polyvinyl acetate crotonic acid	1.3856404300102332
	tablet lubricant	1.3756741032617008
	uniform dispersion	1.3432318298959978
	Pennsylvania1	1.3192504168789256
	less water soluble polymer	1.241084063176905
	combination polymer vehicle	0.8890563239160854
	optionally pharmaceutically acceptable dye	0.5754586801632193
	Parkinson disease	0.5476993082487734
	certain polymeric vehicle	0.4911536254964624
	EMI Group	0.4831754853048873
	prosecution history ESTOPPEL	0.44008446813741503
	control release formulation	0.2819380341810069
	fatty material	0.2652396518758634
	administration	0.2568883943106246
	specie	0.22828724146515356
	immediate release formulation	0.21849299153332974
	control release preparation	0.20266383531230991
	equivalency	0.18334531970605547
	oral dosage formulation	0.16062786389241243
	desire control release	0.14260498785398096
	Ultraseal	0.1115864936353008
	Intel Corp.	0.09403314327657225
	mixture	0.08431743984924939
	Pauline Newman	0.06066803852373416
	drug combination	0.0362433664436916
	phenomenon	0.031257089325135275
	propose genus	0.03083182075447707
	coverage	0.028149580487499513
	prosecution history estoppel	0.026232404116598645
	North America	0.02401060245826339
	Food Drug Administration	0.017671571114446217
	Abbreviated New Drug Application	0.013561139575914996
	equivalent	0.010332871751236426
	charge	0.0075057575113953705
	result amendment	0.007170561231778363
	patentability rejection	0.004933204274224032
	literal infringement	0.004920696550194762
	examination purpose	0.004460798129732385
	Eastern District	0.0042619009468776335
	noninfringement	0.003275443673958891
	specific composition	0.0024969882629056295
	examiner rejection	0.002352654681475905
	initial application	0.00229852451068418
	side effect	0.00115250481429018
	broad	0.0007133131604885739
	response	0.0006722294093267005
	prior art preclude	0.00035026275536310394
	summary judgment	0.00019553419856720982
	certain reference	0.00015952175028295757
	addition	0.00013846096174570768
	certain prior art	0.00010597864468248775
	four application	0.00010086463266450605
	emphasis	8.688205669582382e-05
	suit	8.12423817301318e-05
	de novo	6.636019140628521e-05
	Ltd.	2.913548037269947e-05
	view	1.067713225023764e-05
	patentee	9.404020168659406e-06
	part	8.448024646587364e-06
	light	3.2573522352192727e-06
	time	8.29491343130863e-07
	action	5.753875515369945e-07
	two	3.213199948060291e-08
	district court	2.417081724603733e-09
	fact	2.2164056855147883e-09
	Court	0.0
	Appeals	0.0
	Inc.	0.0
